San Diego, CA -- (SBWIRE) -- 03/01/2016 -- An investigation for shareholders in Johnson & Johnson (NYSE:JNJ) was announced over potential breaches of fiduciary duties by certain Johnson & Johnson directors in connection with the company's vaginal-mesh inserts that allegedly injured thousands of women and left them in constant pain due to mesh surgical inserts eroding in their bodies.

Investors who purchased shares of Johnson & Johnson (NYSE:JNJ) and currently hold any of those NYSE:JNJ shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Johnson & Johnson directors breached their fiduciary duties and caused damage to the company and its shareholders.

Johnson & Johnson reported that its Total Revenue declined from over $71.31 billion for the 12 months period that ended on December 29, 2013 to over $70.07 billion for the 12 months period that ended on January 3, 2016 while its Net Income for those time periods increased from over $13.83 billion to over $15.4 billion. Shares of Johnson & Johnson (NYSE:JNJ) grew from $58.57 per share in March 2011 to as high as $108.51 per share in late 2014. During 2015 NYSE:JNJ shares declined to as low as $91.00 per share in September 2015.

On February 26, 2016, NYSE:JNJ shares closed at $105.78 per share.

Those who purchased shares of Johnson & Johnson (NYSE:JNJ), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com